VESCHI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 430
EU - Europa 105
AS - Asia 72
AF - Africa 8
Totale 615
Nazione #
US - Stati Uniti d'America 427
IT - Italia 51
SG - Singapore 31
IN - India 26
SE - Svezia 17
CN - Cina 15
FI - Finlandia 11
TG - Togo 8
DE - Germania 7
GB - Regno Unito 5
FR - Francia 4
BG - Bulgaria 3
IE - Irlanda 3
CA - Canada 2
RO - Romania 2
UA - Ucraina 2
MX - Messico 1
Totale 615
Città #
Fairfield 79
Woodbridge 35
Seattle 31
Ashburn 30
Ann Arbor 25
Rome 24
Chandler 23
Houston 22
Wilmington 22
Dearborn 21
Cambridge 19
Singapore 13
Princeton 10
San Paolo di Civitate 10
Bethesda 9
Lomé 8
Plano 8
Beijing 7
Lawrence 7
Grafing 6
Fremont 5
Millbury 5
Centrale 4
San Diego 4
Boston 3
Dublin 3
Fuzhou 3
Helsinki 3
New York 3
Sofia 3
Andover 2
Buffalo 2
Des Moines 2
Falls Church 2
Hefei 2
Kolkata 2
Los Angeles 2
Palermo 2
Redwood City 2
Tremestieri Etneo 2
Acton 1
Bremen 1
Chevy Chase 1
Greenwich 1
Hebei 1
Jinan 1
Kunming 1
London 1
Montréal 1
New Bedfont 1
Phoenix 1
Pune 1
Redmond 1
Samassi 1
San Benedetto del Tronto 1
Sezze 1
Southend 1
Toronto 1
Yellow Springs 1
Totale 484
Nome #
The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress 106
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1 79
Molecular mechanisms of MYCN-dependent apoptosis and the MDM2-p53 pathway: an Achille's heel to be exploited for the therapy of MYCN-amplified neuroblastoma. 77
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma 74
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis 74
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells 68
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 59
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response 49
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 21
Developing selective SETD8 inhibitors for treating high-risk neuroblastoma 11
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells 5
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2 4
Cancer cell targeting by CAR-T cells: A matter of stemness 3
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment 3
Targeting chromosomal passenger complex by disruption of INCENP function inhibits tumor progression in neuroblastoma 3
Whole genome screen to identify genes targeting MYCN-driven embryonal tumors 3
Meeting the Challenge of Targeting Cancer Stem Cells 3
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 2
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 2
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 2
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy to reactivate p53 in high-risk neuroblastoma 2
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 2
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer 2
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 2
Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options 2
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 2
Targeting MYCN in Pediatric and Adult Cancers 1
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis 1
High-SETD8 inactivates p53 in neuroblastoma 1
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 1
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review 1
Targeting the chromosomal passenger complex subunit INCENP induces polyploidization, apoptosis, and senescence in neuroblastoma 1
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment 1
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity 1
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 1
Targeting epigenetic alterations in cancer stem cells 1
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 1
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150 increases the chemosensitivity and decreases tumor initiating potential of neuroblastoma cells 1
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy 1
Totale 673
Categoria #
all - tutte 2.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 27 29
2019/2020175 26 3 6 4 20 35 23 16 15 13 11 3
2020/202148 6 3 1 3 3 7 2 2 2 16 3 0
2021/2022101 0 6 13 2 16 2 2 10 3 12 19 16
2022/2023105 15 33 7 5 11 12 0 5 13 1 1 2
2023/2024111 3 6 1 2 9 8 29 17 5 7 24 0
Totale 673